NEW YORK (GenomeWeb News) – Ivan Trifunovich is leaving Helicos BioSciences, the company disclosed in a document filed with the US Securities and Exchange Commission after the close of the market on Thursday.

Helicos said that Trifunovich is resigning as president and CEO effective Sept. 14 and resigned as executive chairman of Helicos' board on Aug. 31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.